Skip to main content
Premium Trial:

Request an Annual Quote

Chris Linthwaite

Fluidigm has appointed Chris Linthwaite as president and chief operating officer. He will report directly to CEO Gajus Worthington. Linthwaite joins Fluidigm from the genetic sciences division of Thermo Fisher Scientific where he served as president. He also served as president of the BioProduction division at Life Technologies, a Thermo Fisher subsidiary.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.